Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes

Journal of the American Academy of Child and Adolescent Psychiatry
Donna R PalumboCAT STUDY TEAM

Abstract

To determine the efficacy and safety of clonidine, used alone or in combination with methylphenidate, in treating attention-deficit/hyperactivity disorder (ADHD). A 16-week, randomized, double-blind, placebo-controlled clinical trial was conducted in 122 children, ages 7 to 12, with any subtype of ADHD, randomly assigned to clonidine, methylphenidate, clonidine in combination with methylphenidate, or placebo according to a 2 x 2 factorial design. In two successive 4-week titration periods, clonidine (or matching placebo) and added methylphenidate (or matching placebo) were adjusted to optimal doses and then continued for 8 weeks. The primary efficacy outcome was changed from baseline to week 16 on the Conners Teachers Abbreviated Symptom Questionnaire. Secondary outcomes included the Conners Abbreviated Symptom Questionnaire for Parents and the Children's Global Assessment Scale. On the Conners Teachers Abbreviated Symptom Questionnaire, clonidine was not found to improve ADHD symptoms, whereas subjects treated with methylphenidate showed significant improvement compared to those not treated with methylphenidate. Subjects treated with clonidine had greater improvements on the Conners Abbreviated Symptom Questionnaire for Parent...Continue Reading

References

Jun 1, 1978·Journal of Abnormal Child Psychology·C H GoyetteR F Ulrich
Mar 11, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·W E PelhamR Milich
May 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·K D GadowJ Sverd
Apr 1, 1991·Archives of General Psychiatry·J F LeckmanD J Cohen
Mar 1, 1985·Journal of Abnormal Child Psychology·M S AtkinsM H Licht
Nov 1, 1983·Archives of General Psychiatry·D ShafferS Aluwahlia
Sep 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·P B ChappellD J Cohen
Jan 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·R D HuntM D Asbell
May 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·P W FisherD B Herzog
Apr 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·D P CantwellD F Connor
Dec 22, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·D F ConnorJ M Swanson
Feb 28, 2002·Neurology·UNKNOWN Tourette's Syndrome Study Group
Jul 23, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Philip L Hazell, John E Stuart
Jan 10, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·W Burleson DavissUNKNOWN CAT STUDY TEAM

❮ Previous
Next ❯

Citations

Jun 13, 2009·Journal of Child and Adolescent Psychopharmacology·Floyd R SalleeJames J McGough
Nov 3, 2009·Journal of Child and Adolescent Psychopharmacology·Timothy E WilensKerry Brodziak
Feb 20, 2010·Journal of Child and Adolescent Psychopharmacology·Jonathan R StevensTimothy E Wilens
Nov 3, 2009·Journal of Child and Adolescent Psychopharmacology·Michael CannonW Burl Daviss
Jun 11, 2010·Journal of Developmental and Behavioral Pediatrics : JDBP·Daniel F ConnorKeith McBurnett
Sep 29, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Christophe PerruchoudEric Buchser
Nov 15, 2011·Child and Adolescent Psychiatry and Mental Health·Cristan A FarmerMichael G Aman
Sep 2, 2009·Neuropsychiatric Disease and Treatment·Rajasree Nair, Shannon B Moss
Dec 2, 2010·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Philip Hazell
Feb 18, 2016·Journal of Child and Adolescent Psychopharmacology·Tina GurnaniJeffrey H Newcorn
Jul 20, 2013·Expert Opinion on Pharmacotherapy·Nisha Warikoo, Stephen V Faraone
Mar 15, 2012·Expert Opinion on Drug Metabolism & Toxicology·Sophie DuongSharon B Wigal
May 24, 2011·Pediatric Clinics of North America·Penny CorkumMarilyn Macpherson
May 3, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gigi H H van de Loo-NeusJan K Buitelaar
Oct 20, 2009·Child and Adolescent Psychiatric Clinics of North America·Judith A Owens, Sricharan Moturi
Apr 17, 2009·Brain & Development·Pasquale ParisiPaolo Curatolo
Mar 18, 2011·British Journal of Pharmacology·Catharine A Winstanley
Sep 3, 2011·The European Journal of Neuroscience·Emmanuel DecampJay S Schneider
Oct 18, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Stephen V Faraone, Yanli Zhang-James
Apr 14, 2015·The American Journal on Addictions·Timothy WilensIsela Catalina-Wellington
Jan 30, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Tomoya HirotaChristoph U Correll
Aug 27, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Simona RuggieroMaurizio Bonati
Apr 29, 2015·Journal of Child and Adolescent Psychopharmacology·Alexander G FiksLaurel K Leslie
Dec 20, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensSharon Youcha
Jul 28, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·James T McCrackenRobert M Bilder
Feb 25, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Yoshiyuki Ohtomo
Oct 7, 2009·Journal of Child Neurology·Elisa D'AgatiPaolo Curatolo
May 8, 2013·Journal of Central Nervous System Disease·Anna C ShierJaswinder K Ghuman
Nov 26, 2015·The Cochrane Database of Systematic Reviews·Ole Jakob StorebøChristian Gluud
Apr 4, 2017·Journal of Attention Disorders·Danielly Chierrito de OliveiraAndréia Cristina Conegero Sanches
Apr 24, 2013·Journal of Child and Adolescent Psychopharmacology·Kathryn Yuill, Carlo Carandang
Dec 24, 2008·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Frank HässlerJohannes Buchmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.